Knowledge hub

News

AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2

Agnieszka Blum, PhD MD, joins Ardigen as the General Director of Immunology
Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies
PRISM – a writing assistant for the language of proteins
AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2
Leveraging biomarkers to bring the right treatment to the right patient
Ardigen enters into research collaboration with CVC to apply Artificial Intelligence for identification of T-cell targets – press release
Fishing out hypotheses from a sea of data: how Ardigen’s AIKE helps scientists ask better questions
AACR poster -2
Microbial signatures of response to anti-PD1 therapy in metastatic melanoma patients
News

AACR poster – 1
Accounting for immune escape mechanisms in personalized and shared neoantigen cancer vaccine design

Understanding microbial proteins with deep learning – part 2
Understanding microbial proteins with deep learning – part 1
Selvita and Ardigen will receive funding for the development of an AI-based high-content screening platform
We are ready to support your efforts in the fight against COVID-19
Safety considerations for COVID-19 vaccines and antibody-based therapies
The microbiome as a potential weapon against novel coronavirus SARS-CoV-2
Ardigen at AI Powered Drug Discovery and Manufacturing Conference
A new publication about molecule property prediction: Molecule Attention Transformer